Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $99.7B |
| FY2017, ended Dec 31, 2017 | $103B |
| FY2018, ended Dec 31, 2018 | $83.9B |
| FY2019, ended Dec 31, 2019 | $100B |
| FY2020, ended Dec 31, 2020 | $146B |
| FY2021, ended Dec 31, 2021 | $187B |
| FY2022, ended Dec 31, 2022 | $149B |
| FY2023, ended Dec 31, 2023 | $134B |
| FY2024, ended Dec 31, 2024 | $108B |
| FY2025, ended Dec 31, 2025 | $84.2B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $91.5B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $61.6B |
| FY2017, ended Dec 31, 2017 | $66.6B |
| FY2018, ended Dec 31, 2018 | $71.9B |
| FY2019, ended Dec 31, 2019 | $74.1B |
| FY2020, ended Dec 31, 2020 | $84.6B |
| FY2021, ended Dec 31, 2021 | $97.3B |
| FY2022, ended Dec 31, 2022 | $100B |
| FY2023, ended Dec 31, 2023 | $91.0B |
| FY2024, ended Dec 31, 2024 | $91.1B |
| FY2025, ended Dec 31, 2025 | $88.7B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $89.9B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $3.42B | $3.51B |
| FY2017, ended Dec 31, 2017 | $4.91B | −$3.75B |
| FY2018, ended Dec 31, 2018 | $4.79B | $6.43B |
| FY2019, ended Dec 31, 2019 | $4.44B | $2.26B |
| FY2020, ended Dec 31, 2020 | $1.34B | $5.05B |
| FY2021, ended Dec 31, 2021 | $12.9B | $10.8B |
| FY2022, ended Dec 31, 2022 | $11.5B | $9.34B |
| FY2023, ended Dec 31, 2023 | $6.71B | $5.08B |
| FY2024, ended Dec 31, 2024 | $5.78B | $6.21B |
| FY2025, ended Dec 31, 2025 | $5.57B | $4.76B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $4.57B | $5.46B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.48B |
| FY2017, ended Dec 31, 2017 | $3.32B |
| FY2018, ended Dec 31, 2018 | $4.22B |
| FY2019, ended Dec 31, 2019 | $5.24B |
| FY2020, ended Dec 31, 2020 | $5.91B |
| FY2021, ended Dec 31, 2021 | $10.3B |
| FY2022, ended Dec 31, 2022 | $5.60B |
| FY2023, ended Dec 31, 2023 | $3.21B |
| FY2024, ended Dec 31, 2024 | $6.11B |
| FY2025, ended Dec 31, 2025 | $5.89B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $4.65B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $15.6B |
| FY2017, ended Dec 31, 2017 | $23.9B |
| FY2018, ended Dec 31, 2018 | $22.3B |
| FY2019, ended Dec 31, 2019 | $28.3B |
| FY2020, ended Dec 31, 2020 | $24.5B |
| FY2021, ended Dec 31, 2021 | $21.7B |
| FY2022, ended Dec 31, 2022 | $19.4B |
| FY2023, ended Dec 31, 2023 | $22.0B |
| FY2024, ended Dec 31, 2024 | $21.0B |
| FY2025, ended Dec 31, 2025 | $23.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $24.5B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 2.2% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 870M |
| FY2017, ended Dec 31, 2017 | 862M |
| FY2018, ended Dec 31, 2018 | 860M |
| FY2019, ended Dec 31, 2019 | 858M |
| FY2020, ended Dec 31, 2020 | 867M |
| FY2021, ended Dec 31, 2021 | 870M |
| FY2022, ended Dec 31, 2022 | 859M |
| FY2023, ended Dec 31, 2023 | 853M |
| FY2024, ended Dec 31, 2024 | 854M |
| FY2025, ended Dec 31, 2025 | 849M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 851M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.68B | $591M | $245M |
| FY2017, ended Dec 31, 2017 | $1.81B | $584M | $247M |
| FY2018, ended Dec 31, 2018 | $1.01B | $634M | $240M |
| FY2019, ended Dec 31, 2019 | $1.00B | $915M | $218M |
| FY2020, ended Dec 31, 2020 | $224M | $796M | $285M |
| FY2021, ended Dec 31, 2021 | $500M | $878M | $251M |
| FY2022, ended Dec 31, 2022 | $3.50B | $1.57B | $262M |
| FY2023, ended Dec 31, 2023 | $2.25B | $220M | $248M |
| FY2024, ended Dec 31, 2024 | $500M | $24.0M | $232M |
| FY2025, ended Dec 31, 2025 | $1.00B | $73.0M | $159M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $0 | $115M | $117M |
Valuation
At current price- Market Cap
- $90.3B
- P/E
- 19.8×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 1.0×
- Price / Book
- 6.0×
- EV / EBITDA
- 11.4×
Growth
Trailing 12 months- Revenue (TTM)
- $89.9B
- Revenue Growth YoY
- −0.4%
- Revenue CAGR 3Y
- −4.0%
- Revenue CAGR 5Y
- 0.9%
- EPS Growth YoY
- −19.9%
- Net Income Growth YoY
- −20.2%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 7.3%
- Net Margin
- 5.1%
- FCF Margin
- 6.1%
- Return on Equity
- 29.7%
Earnings
Trailing 12 months- Net Income
- $4.57B
- EPS (diluted)
- $5.38
- EBITDA
- $9.68B
- Operating Income
- $6.58B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $4.65B
- Total Debt
- $24.5B
- Net Debt
- $19.8B
- Total Assets
- $71.3B
- Total Liabilities
- $56.2B
- Shareholders' Equity
- $15.1B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $8.87B
- Capital Expenditure
- $3.41B
- Free Cash Flow
- $5.46B
Dividends and risk
Last 12 months- Dividend Yield
- 6.2%
- Dividend / Share
- $6.56
- Beta (5Y)
- 1.07
Every ratio is calculated from the company’s reported figures.